Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Tolerability of Eptinezumab: a Prospective, Multicentric, Cohort Study

NCT06409845 is registered in ClinicalTrials.gov with University of Florence as lead sponsor.

NCT NCT06409845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06409845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Tolerability of Eptinezumab: a Prospective, Multicentric, Cohort Study
Lead sponsor
University of Florence
Phase
Observational
Overall status
Completed
Start date
March 26, 2024
Completion date
April 1, 2026
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, migraine, migraine with aura, migraine without aura